When it comes to potency, there’s truly something for everyone. Cornbread Hemp offers three strength options: 375 mg CBD/15 ...

SOLANA BEACH, Calif. - Artelo Biosciences , Inc. (NASDAQ:ARTL), a clinical-stage biopharmaceutical company with a market capitalization of $4.5 million, announced nonclinical results for its ...

Approved to treat epilepsy In 2018, the first FDA-approved drug containing CBD, cannabidiol (Epidiolex), was released in the market to treat two different kinds of epilepsy: Dravet syndrome and ...

Cannabidiol may reduce scan-related anxiety among women with advanced breast cancer, according to results of randomized phase ...

New research reveals how CBD and THC interact with brain receptors, unlocking potential for safer cannabis-based treatments.

Scientists reveal how CBD could help ease chronic pain, anxiety, and mood disorders. Researchers have uncovered a potential ...

The Food and Drug Administration (FDA) hasn’t approved any medications containing CBD for pain relief, and additional research is necessary to determine CBD’s ability to reduce pain ...

Still, emerging research is currently exploring the many ways CBD may impact the body across an array of conditions. Currently, the only U.S. Food and Drug Administration (FDA)-approved medication ...

When THC attaches to the receptor, the effect is like an off switch to a light bulb, effectively turning "off" the pain. But ...

CBD is not psychoactive and does not cause a “high” or intoxication like tetrahydrocannabinol (THC). Epidiolex, a drug prescribed for epilepsy, is the only CBD product on the market that the ...

CBD may hold promise as a tool to help people reduce problem drinking, according to a new study published in Alcohol: ...

A new study has uncovered potential risks, including impaired fetal growth, associated with the use of both tetrahydrocannabinol (THC), the primary psychoactive component of cannabis, as well as CBD, ...